Literature DB >> 2245668

Utility of fiberoptic bronchoscopy in nonresolving pneumonia.

S H Feinsilver1, A M Fein, M S Niederman, D E Schultz, D H Faegenburg.   

Abstract

Although fiberoptic bronchoscopy (FOB) has been traditionally used to evaluate nonresolving pneumonia, its efficacy is unknown. We, therefore, reviewed FOB in 35 consecutive patients who had (1) a roentgenographic infiltrate, (2) cough, (3) either temperature greater than 38.1 degrees C, leukocytosis, sputum production, (4) symptoms present for at least ten days, and antibiotic therapy for at least one week. Known lung cancer and AIDS were excluded. Fiberoptic bronchoscopy was diagnostic in 86 percent (12/14) in whom a specific cause was found. No patient had endobronchial cancer. Two patients with nondiagnostic FOB and persistent systemic symptoms had open lung biopsy specimens showing Wegener's granulomatosis and bronchiolitis obliterans with organizing pneumonia (BOOP). Twenty-one patients with nondiagnostic FOB had no final diagnoses other than community-acquired pneumonia. We conclude that FOB is extremely useful in finding a specific diagnosis for a nonresolving pneumonia when a specific diagnosis can be made. Fiberoptic bronchoscopy was most likely to yield a specific diagnosis in nonsmoking patients with multilobar infiltrates of long duration and could have been avoided in older, smoking, or otherwise compromised patients with lobar or segmental infiltrates with no decrease in diagnostic yield in our series.

Entities:  

Mesh:

Year:  1990        PMID: 2245668     DOI: 10.1378/chest.98.6.1322

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  19 in total

Review 1.  The pulmonary physician in critical care . 3: critical care management of community acquired pneumonia.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

2.  Bronchial Wash Gene Xpert MTB/RIF in Lower Lung Field Tuberculosis: Sensitive, Superior, and Rapid in Comparison with Conventional Diagnostic Techniques.

Authors:  Shital Patil; Swati Narwade; Mazhar Mirza
Journal:  J Transl Int Med       Date:  2017-09-30

3.  Diagnostic value of bronchoalveolar lavage in patients with opportunistic and nonopportunistic bacterial pneumonia.

Authors:  K Dalhoff; J Braun; H Hollandt; R Lipp; K J Wiessmann; R Marre
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

Review 4.  Bronchoscopic diagnosis of pneumonia.

Authors:  V S Baselski; R G Wunderink
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 5.  The utility of bronchoscopy in immunocompromised patients: a review.

Authors:  Christopher Morton; Jonathan Puchalski
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

6.  Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; H M Jansen; W G Boersma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

7.  [Progressive upper lobe consolidation in a 73-year old healthy woman].

Authors:  S Tasci; S Lentini; R Manka; N Friedrichs; B Lüderitz
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

8.  Recurrent pneumonia due to an appendiceal mucinous cystadenocarcinoma: a rare presentation of a rare malignancy.

Authors:  Karin G Gerritsen; Peter H Slee; Thomas L Bollen; Wim van Hecke; Cornelis A Seldenrijk; Ruth G Keijsers; Vincent A Duurkens
Journal:  Clin Med Oncol       Date:  2009-03-02

9.  [Update to the Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia].

Authors: 
Journal:  Arch Bronconeumol       Date:  2004-08       Impact factor: 4.872

10.  Pneumococcal antigen detection in bronchoalveolar lavage fluid from patients with pneumonia.

Authors:  P Jiménez; M Meneses; F Saldías; M Velásquez
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.